Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Sinovac Biotech has received emergency use approval for its potential Covid-19 vaccine CoronaVac under a programme in China to vaccinate high-risk groups, according to Reuters citing a person familiar with the matter.
The company started developing the inactivated vaccine against Covid-19 in January this year in alliance with academic research institutes in China.
In preclinical studies, CoronaVac was found to be safe and provided protection to rhesus macaques monkeys. Findings were published in Science journal.